Arena Pharmaceuticals has a new active bullish pattern, levels to watch Shares are currently up 5.5% at time of writing, last at $10.21. There is a bullish pennant now active on the daily chart. The pattern triggered when price rose above $10 and would not be active below this level. Upside potential for the pennant, if it remains active and completes, is to the $11 area.
Arena says Teva files marketing authorization of Belviq in Israel Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.